Aydın Aytekin

421 total citations
25 papers, 259 citations indexed

About

Aydın Aytekin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Aydın Aytekin has authored 25 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Cancer Research. Recurrent topics in Aydın Aytekin's work include Breast Cancer Treatment Studies (7 papers), Cancer Diagnosis and Treatment (4 papers) and Peptidase Inhibition and Analysis (4 papers). Aydın Aytekin is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Cancer Diagnosis and Treatment (4 papers) and Peptidase Inhibition and Analysis (4 papers). Aydın Aytekin collaborates with scholars based in Türkiye. Aydın Aytekin's co-authors include Gökmen Umut Erdem, Süleyman Şahin, Kadri Altundağ, Fatih Karataş, Ali Sever, Yavuz Özışık, Taner Babacan, Umut Elboğa, Deniz Yüce and Öztürk Ateş and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Breast.

In The Last Decade

Aydın Aytekin

19 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aydın Aytekin Türkiye 8 197 102 69 53 48 25 259
Havva Yeşil Çınkır Türkiye 8 138 0.7× 72 0.7× 84 1.2× 21 0.4× 59 1.2× 32 249
Özlem Nuray Sever Türkiye 9 204 1.0× 92 0.9× 87 1.3× 36 0.7× 61 1.3× 38 278
Hanxiang Liu China 10 212 1.1× 91 0.9× 87 1.3× 40 0.8× 120 2.5× 25 325
Xing‐Li Yang China 12 122 0.6× 48 0.5× 101 1.5× 53 1.0× 41 0.9× 23 315
Wichit Arpornwirat Thailand 9 176 0.9× 58 0.6× 53 0.8× 60 1.1× 58 1.2× 17 279
Daniela Paccagnella Italy 8 150 0.8× 54 0.5× 110 1.6× 84 1.6× 24 0.5× 11 361
Marit Ahrens Germany 9 226 1.1× 108 1.1× 108 1.6× 107 2.0× 88 1.8× 22 378
Bruno Gori Italy 8 178 0.9× 37 0.4× 56 0.8× 53 1.0× 72 1.5× 15 339
Feiying Gu China 10 106 0.5× 55 0.5× 51 0.7× 133 2.5× 25 0.5× 11 316
Fiorita Poulakaki Greece 9 111 0.6× 88 0.9× 44 0.6× 42 0.8× 21 0.4× 17 237

Countries citing papers authored by Aydın Aytekin

Since Specialization
Citations

This map shows the geographic impact of Aydın Aytekin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aydın Aytekin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aydın Aytekin more than expected).

Fields of papers citing papers by Aydın Aytekin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aydın Aytekin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aydın Aytekin. The network helps show where Aydın Aytekin may publish in the future.

Co-authorship network of co-authors of Aydın Aytekin

This figure shows the co-authorship network connecting the top 25 collaborators of Aydın Aytekin. A scholar is included among the top collaborators of Aydın Aytekin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aydın Aytekin. Aydın Aytekin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Teker, Fatih, et al.. (2024). Relationship of Neoadjuvant Chemotherapy Efficacy with Histopathologic Molecular Subtypes in Breast Cancer Patients. SHILAP Revista de lepidopterología. 25(4). 274–280.
2.
Elboğa, Umut, et al.. (2024). Prognostic significance of 68 Ga-FAPI PET/CT in patients with bone metastases in various cancers. Annals of Nuclear Medicine. 38(8). 630–638. 4 indexed citations
3.
4.
Aydın, Nasuhi Engin, et al.. (2023). The Impact of the COVID-19 Pandemic on the Diagnosis and Treatment Characteristics of Operated Lung Cancer Patients. Journal of College of Physicians And Surgeons Pakistan. 33(11). 1271–1277.
5.
Elboğa, Umut, Ertan Şahin, Tülay Kuş, et al.. (2022). Comparison of 68Ga-FAPI PET/CT and 18FDG PET/CT Modalities in Gastrointestinal System Malignancies with Peritoneal Involvement. Molecular Imaging and Biology. 24(5). 789–797. 30 indexed citations
6.
Elboğa, Umut, Ertan Şahin, Tülay Kuş, et al.. (2021). Superiority of 68Ga-FAPI PET/CT scan in detecting additional lesions compared to 18FDG PET/CT scan in breast cancer. Annals of Nuclear Medicine. 35(12). 1321–1331. 72 indexed citations
7.
Aytekin, Aydın, et al.. (2021). Prognostic and predictive significance of pd-l1 expression in non-small cell lung cancer patients: a single-center experience. Turkish Journal of Pathology. 37(3). 239–248. 7 indexed citations
8.
Ma, Kaplan, Zeynep Oruç, Mahmut Gümüş, et al.. (2020). The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study.. PubMed. 24(3). 1081–1086. 1 indexed citations
9.
Oruç, Zeynep, Kaplan Ma, Çağlayan Geredeli, et al.. (2020). Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study.. PubMed. 24(2). 1876–1883. 2 indexed citations
10.
Aytekin, Aydın. (2020). Comparison of Vitamin D Levels Between Healthy Individuals and Cancer Patients. Eurasian Journal of Medical Investigation. 5 indexed citations
11.
Erdem, Gökmen Umut, Kadri Altundağ, Nuriye Özdemir, et al.. (2019). Comparative study of receptor discordance between primary and corresponding metastatic lesions in breast cancer.. PubMed. 22(2). 365–376. 13 indexed citations
12.
Erdem, Gökmen Umut, Mutlu Doğan, Aydın Aytekin, et al.. (2019). Clinical outcomes of patients with pure small cell carcinoma of the urinary bladder. Irish Journal of Medical Science (1971 -). 189(2). 431–438. 1 indexed citations
13.
Erdem, Gökmen Umut, Mutlu Doğan, Abdullah Sakin, et al.. (2018). Non-Urothelial Bladder Cancer: Comparison of Clinicopathological and Prognostic Characteristics in Pure Adenocarcinoma and Non-Bilharzial Squamous Cell Carcinoma of the Bladder. Oncology Research and Treatment. 41(4). 220–225. 2 indexed citations
14.
Aytekin, Aydın, et al.. (2018). A metastatic histiocytic sarcoma case with primary involvement of the tonsil. Journal of Cancer Research and Therapeutics. 16(3). 665–667. 1 indexed citations
15.
Karataş, Fatih, Süleyman Şahin, Aydın Aytekin, et al.. (2018). Behçet's disease and breast cancer: A case series study. Journal of Cancer Research and Therapeutics. 14(6). 1184–1190.
16.
Aksoy, Asude, Hatice Odabaş, Serap Kaya, et al.. (2017). Hormone receptor status and survival of medullary breast cancer patients. Saudi Medical Journal. 38(2). 156–162. 9 indexed citations
17.
Aytekin, Aydın, et al.. (2017). A case of membranous glomerulopathy associated with lung cancer and review of the literature. Molecular and Clinical Oncology. 7(2). 241–243. 9 indexed citations
18.
Aytekin, Aydın, Fatih Karataş, Süleyman Şahin, Gökmen Umut Erdem, & Kadri Altundağ. (2017). Clinicopathological features of patients with breast cancer aged 70 years or over.. PubMed. 22(1). 200–207. 3 indexed citations
19.
Şahin, Süleyman, Gökmen Umut Erdem, Fatih Karataş, et al.. (2016). The association between body mass index and immunohistochemical subtypes in breast cancer. The Breast. 32. 227–236. 29 indexed citations
20.
Karataş, Fatih, Gökmen Umut Erdem, Süleyman Şahin, et al.. (2016). Obesity is an independent prognostic factor of decreased pathological complete response to neoadjuvant chemotherapy in breast cancer patients. The Breast. 32. 237–244. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Havva Yeşil Çınkır Breakdown of academic impact, for papers by Özlem Nuray Sever Breakdown of academic impact, for papers by Hanxiang Liu Breakdown of academic impact, for papers by Xing‐Li Yang Breakdown of academic impact, for papers by Wichit Arpornwirat Breakdown of academic impact, for papers by Daniela Paccagnella Breakdown of academic impact, for papers by Marit Ahrens Breakdown of academic impact, for papers by Bruno Gori Breakdown of academic impact, for papers by Feiying Gu Breakdown of academic impact, for papers by Fiorita Poulakaki
Rankless by CCL
2026